Form 4 for IDA IDACORP INC
Accepted 2025-08-12 00:00:00 ET · period of report 2025-01-01 · accession 0002078099-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-12 | 2025-01-01 | IDA | Tatum Timothy E | VP Regulatory Affairs | M - OptEx | $0.00 | +535 | 1,767 | +43% | $0 |
| D | 2025-08-12 | 2025-03-12 | IDA | Tatum Timothy E | VP Regulatory Affairs | S - Sale+OE | $115.34 | -2,006 | 58.78 | -97% | -$231.4K |
| DM | 2025-08-12 | 2025-01-02+ | IDA | Tatum Timothy E | VP Regulatory Affairs | F - Tax | $112.21 | -775 | 1,497 | -34% | -$87.0K |
| D | 2025-08-12 | 2025-02-21 | IDA | Tatum Timothy E | VP Regulatory Affairs | A - Grant | — | +1,070 | 2,567 | +71% | — |
| D | 2025-08-12 | 2025-01-01 | IDA | Tatum Timothy E | VP Regulatory Affairs | M - OptEx | $0.00 | -535 | 0 | -100% | $0 |
| D | 2025-08-12 | 2025-02-21 | IDA | Tatum Timothy E | VP Regulatory Affairs | A - Grant | $0.00 | +684 | 684 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-01 | M | A | 535 | $0.00 | 1,767.41 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of IDA common stock. (F2) Includes 56.410 shares in the reporting person's dividend reinvestment plan as of the transaction date. |
| 2 | Common | Common Stock | 2025-03-12 | S | D | 2,006 | $115.34 | 58.78 | D | — | — | (F4) Comprised of 58.777 shares in the reporting person's dividend reinvestment plan as of the transaction date. |
| 3 | Common | Common Stock | 2025-02-21 | F | D | 505 | $114.20 | 2,062.41 | D | — | — | (F2) Includes 56.410 shares in the reporting person's dividend reinvestment plan as of the transaction date. |
| 4 | Common | Common Stock | 2025-02-21 | A | A | 1,070 | — | 2,567.41 | D | — | — | (F3) These shares were received for no consideration upon the satisfaction of performance criteria underlying an award of performance-based units for the 2022-2024 performance period. (F2) Includes 56.410 shares in the reporting person's dividend reinvestment plan as of the transaction date. |
| 5 | Common | Common Stock | 2025-01-02 | F | D | 270 | $108.49 | 1,497.41 | D | — | — | (F2) Includes 56.410 shares in the reporting person's dividend reinvestment plan as of the transaction date. |
| 6 | Derivative | Restricted Stock Units | 2025-01-01 | M | D | 535 | $0.00 | 0 | D | $0.00 · — to — | 535 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of IDA common stock. (F6) The restricted stock units vested on January 1, 2025. |
| 7 | Derivative | Restricted Stock Units | 2025-02-21 | A | A | 684 | $0.00 | 684 | D | $0.00 · — to — | 684 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of IDA common stock. (F7) The restricted stock units vest on January 1, 2028. |